tiprankstipranks
Trending News
More News >
Innate Pharma SA Sponsored ADR (IPHA)
:IPHA
Advertisement

Innate Pharma (IPHA) Revenue

Compare
118 Followers

Innate Pharma Revenue

Innate Pharma had a revenue of 276.00K in the quarter ending Dec 31, 2024, with -97.76%. This bring the company's revenue in the last twelve months to 12.62M, Increased -62.65%. In the fiscal year ending Dec 31, 2024, Innate Pharma had annual revenue of 12.62M with -75.68% growth.
Revenue (ttm)
12.62M
Revenue Growth
-75.67%
P/S Ratio
12.75
Revenue/Employee
$69,729
Employees
181
Market Cap
$160.97M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
12.62M-39.28M-75.68%
Dec 31, 2023
51.90M-5.77M-10.01%
Dec 31, 2022
57.67M45.56M+376.17%
Dec 31, 2021
12.11M-57.66M-82.64%
Dec 31, 2020
69.77M800.00K+1.16%
Dec 31, 2019
68.97M-10.92M-13.67%
Dec 31, 2018
79.89M47.26M+144.83%
Dec 31, 2017
32.63M-23.53M-41.90%
Dec 31, 2016
56.16M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis